Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters

BACKGROUND: Breast cancer pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) varies with tumor subtype. The purpose of this study was to identify an early treatment window for predicting pCR based on tumor subtype, pretreatment total hemoglobin (tHb) level, and early changes in tHb...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Quing, Tannenbaum, Susan, Kurtzman, Scott H., DeFusco, Patricia, Ricci, Andrew, Vavadi, Hamed, Zhou, Feifei, Xu, Chen, Merkulov, Alex, Hegde, Poornima, Kane, Mark, Wang, Liqun, Sabbath, Kert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001175/
https://www.ncbi.nlm.nih.gov/pubmed/29898762
http://dx.doi.org/10.1186/s13058-018-0975-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001175/
https://www.ncbi.nlm.nih.gov/pubmed/29898762
http://dx.doi.org/10.1186/s13058-018-0975-1

Ejemplares similares